Protecting the kidney against autoimmunity and inflammation
- PMID: 30559368
- DOI: 10.1038/s41581-018-0097-0
Protecting the kidney against autoimmunity and inflammation
Similar articles
-
The immune system and kidney disease: basic concepts and clinical implications.Nat Rev Immunol. 2013 Oct;13(10):738-53. doi: 10.1038/nri3523. Epub 2013 Sep 16. Nat Rev Immunol. 2013. PMID: 24037418 Review.
-
Resident TH17 cells "break bad" in kidney autoimmunity.Sci Immunol. 2020 Aug 7;5(50):eabd3638. doi: 10.1126/sciimmunol.abd3638. Sci Immunol. 2020. PMID: 32769173
-
T cells and autoimmune kidney disease.Nat Rev Nephrol. 2017 Jun;13(6):329-343. doi: 10.1038/nrneph.2017.34. Epub 2017 Mar 13. Nat Rev Nephrol. 2017. PMID: 28287110 Review.
-
The NLRP3 inflammasome in kidney disease and autoimmunity.Nephrology (Carlton). 2016 Sep;21(9):736-44. doi: 10.1111/nep.12785. Nephrology (Carlton). 2016. PMID: 27011059 Review.
-
The protective effect of miR-377 inhibitor against renal ischemia-reperfusion injury through inhibition of inflammation and oxidative stress via a VEGF-dependent mechanism in mice.Mol Immunol. 2019 Feb;106:153-158. doi: 10.1016/j.molimm.2018.12.028. Epub 2019 Jan 3. Mol Immunol. 2019. PMID: 30612004
Cited by
-
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.Cell Death Dis. 2023 Sep 9;14(9):601. doi: 10.1038/s41419-023-06124-0. Cell Death Dis. 2023. PMID: 37689694 Free PMC article.
-
Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: A biomarker and potential therapeutic target.Chin Med J (Engl). 2024 Jul 20;137(14):1663-1673. doi: 10.1097/CM9.0000000000003197. Epub 2024 May 28. Chin Med J (Engl). 2024. PMID: 38809056 Free PMC article. Review.
-
Signaling pathways of chronic kidney diseases, implications for therapeutics.Signal Transduct Target Ther. 2022 Jun 9;7(1):182. doi: 10.1038/s41392-022-01036-5. Signal Transduct Target Ther. 2022. PMID: 35680856 Free PMC article. Review.
-
The podocytes' inflammatory responses in experimental GN are independent of canonical MYD88-dependent toll-like receptor signaling.Sci Rep. 2024 Jan 27;14(1):2292. doi: 10.1038/s41598-024-52565-8. Sci Rep. 2024. PMID: 38280906 Free PMC article.
-
The role and mechanism of TSC in kidney diseases: a literature review.BMC Nephrol. 2025 Jul 1;26(1):316. doi: 10.1186/s12882-025-04260-7. BMC Nephrol. 2025. PMID: 40597820 Free PMC article. Review.
References
-
- McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A. & Smith, K. G. C. T cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612–616 (2015). - DOI
-
- Chen, A. et al. Bowman’s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J. Clin. Invest. 128, 3413–3424 (2018). - DOI
-
- Heymann, F. et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J. Clin. Invest. 119, 1286–1297 (2009). - DOI
-
- Goldwich, A. et al. Podocytes are nonhematopoietic professional antigen-presenting cells. J. Am. Soc. Nephrol. 24, 906–916 (2013). - DOI
-
- Niedermeier, M. et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl Acad. Sci. USA 106, 17892–17897 (2009). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical